154
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?

, ORCID Icon, , , &
Pages 2275-2283 | Published online: 15 Jul 2022

References

  • Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313.e1–319.e1. doi:10.1016/j.ophtha.2009.07.017
  • Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8:1886–1894. doi:10.1111/j.1538-7836.2010.03909.x
  • Yau JWY, Lee P, Wong TY, Best J, Jenkins A. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J. 2008;38:904–910. doi:10.1111/j.1445-5994.2008.01720.x
  • Ho JD, Liou SW, Lin HC. Retinal vein occlusion and the risk of stroke development: a five-year follow-up study. Am J Ophthalmol. 2009;147:283–290. doi:10.1016/j.ajo.2008.08.006
  • Yin X, Li J, Zhang B, Lu P. Association of glaucoma with risk of retinal vein occlusion: a meta-analysis. Acta Ophthalmol. 2019;97:652–659. doi:10.1111/aos.14141
  • Pulido JS, Flaxel CJ, Adelman RA, et al. Retinal vein occlusions preferred practice pattern guidelines. Ophthalmology. 2016;123:182–208. doi:10.1016/j.ophtha.2015.10.045
  • Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a Phase III study. Ophthalmology. 2011;118:1594–1602. doi:10.1016/j.ophtha.2011.02.022
  • Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology. 2015;122:538–544. doi:10.1016/j.ophtha.2014.08.031
  • Son Y, Lee S, Park J. Measurement of lamina and prelaminar thicknesses of both eyes in patients with unilateral branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2017;255:503–508. doi:10.1007/s00417-016-3491-y
  • Park HYL, Jeon S, Lee MY, Park CK. Glaucoma progression in the unaffected fellow eye of glaucoma patients who developed unilateral branch retinal vein occlusion. Am J Ophthalmol. 2017;175:194–200. doi:10.1016/j.ajo.2016.10.009
  • Mac Donald D. The ABCs of RVO: a review of retinal venous occlusion. Clin Exp Optom. 2014;97:311–323. doi:10.1111/cxo.12120
  • Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000;107:1287–1293. doi:10.1016/S0161-6420(00)00138-X
  • Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–393. doi:10.1016/s1350-9462(02)00008-3
  • Flammer J, Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res. 1998;17:267–289. doi:10.1016/S1350-9462(97)00006-2
  • Sung KR, Cho JW, Lee S, et al. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2011;52:737–743. doi:10.1167/iovs.10-5351
  • Wang Q, Chan SY, Yan Y, et al. Optical coherence tomography angiography in retinal vein occlusions. Graefes Arch Clin Exp Ophthalmol. 2018;256:1615–1622. doi:10.1007/s00417-018-4038-1
  • Maltsev DS, Kulikov AN, Kazak AA, Burnasheva MA. Status of choriocapillaris in fellow eyes of patients with unilateral retinal vein occlusions. Ophthalmic Surg Lasers Imaging Retina. 2021;52:23–28. doi:10.3928/23258160-20201223-05
  • Sin BH, Song BJ, Park SP. Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma. J Glaucoma. 2013;22:104–109. doi:10.1097/IJG.0b013e3182312047
  • Loesch A. Perivascular nerves and vascular endothelium: recent advances. Histol Histopathol. 2002;17:591–597. doi:10.14670/HH-17.591
  • Kida T, Flammer J, Oku H, et al. Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision. EPMA J. 2016;7:18. doi:10.1186/s13167-016-0066-2
  • Chan EW, Wong TY, Liao J, et al. Branch retinal vein occlusion and optic nerve head topographic parameters: the Singapore Indian eye study. Br J Ophthalmol. 2013;97:611–616. doi:10.1136/bjophthalmol-2012-302280
  • Terashima H, Okamoto F, Hasebe H, Ueda E, Yoshida H, Fukuchi T. Optical coherence tomography angiography and Humphrey field analyser for macular capillary non-perfusion evaluation in branch retinal vein occlusion. Sci Rep. 2021;11(1):4583. doi:10.1038/s41598-021-84240-7
  • Kim CS, Shin KS, Lee HI, Jo YJ, Kim JY. Sectoral retinal nerve fiber layer thinning in branch retinal vein occlusion. Retina. 2014;34:525–530. doi:10.1097/IAE.0b013e3182a2e746
  • Alshareef RA, Barteselli G, You O, et al. In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion. Br J Ophthalmol. 2016;100:1506–1510. doi:10.1136/bjophthalmol-2015-308106
  • Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525–536.
  • Hayreh SS. Prevalent mis conceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005;24:493–519. doi:10.1016/j.preteyeres.2004.12.001
  • Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol. 1990;109:298–302. doi:10.1016/S0002-9394(14)74554-4
  • Feist RM, Ticho BH, Shapiro MJ, Farber M. Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am J Ophthalmol. 1992;113:664–668. doi:10.1016/S0002-9394(14)74791-9
  • Venkatesh R, Pereira A, Sangai S, Thomas S, Yadav NK. Prognostic value of hyperreflective material on visual acuity in treatment-naïve BRVO. Ophthalmic Surg Lasers Imaging Retina. 2020;51:320–327. doi:10.3928/23258160-20200603-02
  • Hykin P, Prevost AT, Vasconcelos JC, et al. Clinical effectiveness of intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for macular edema secondary to central retinal vein occlusion: a randomized clinical trial. JAMA Ophthalmol. 2019;137:1256–1264. doi:10.1001/jamaophthalmol.2019.3305
  • Sangroongruangsri S, Ratanapakorn T, Wu O, Anothaisintawee T, Chaikledkaew U. Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis. Expert Rev Clin Pharmacol. 2018;11:903–916. doi:10.1080/17512433.2018.1507735
  • Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six month primary end point results of a phase III study. Ophthalmology. 2010;117:1102–1112. doi:10.1016/j.ophtha.2010.02.021
  • Ito Y, Saishin Y, Sawada O, et al. Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. Clin Ophthalmol. 2015;9:175–180. doi:10.2147/OPTH.S76261
  • Bayat AH, Çakır A, Özturan ŞG, et al. Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion. Int J Ophthalmol. 2018;11:1534–1538. doi:10.18240/ijo.2018.09.17
  • Chen X, Hu TM, Zuo J, et al. Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections. BMC Ophthalmol. 2020;20:225. doi:10.1186/s12886-020-01494-x
  • Beato J, Pedrosa AC, Pinheiro-Costa J, et al. Long-term effect of anti-VEGF agents on intraocular pressure in age-related macular degeneration. Ophthalmic Res. 2016;56:30–34. doi:10.1159/000444395
  • de Vries VA, Bassil FL, Ramdas WD. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep. 2020;10:132. doi:10.1038/s41598-020-70269-7
  • Holló G, Aung T, Cantor LB, Aihara M. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol. 2020;65:496–512. doi:10.1016/j.survophthal.2020.02.004
  • Dichtl A, Jonas JB, Naumann GO. Retinal nerve fiber layer thickness in human eyes. Grafes Arch Clin Exp Ophthalmol. 1999;237:474–479. doi:10.1007/s004170050264
  • Kubota T, Khalil AK, Honda M, et al. Comparative study of retinal nerve fiber layer damage in Japanese patients with normal- and high-tension glaucoma. J Glaucoma. 1999;8(6):363–366. doi:10.1097/00061198-199912000-00004